Synthetic Biologics

+$0.0055 (+1.12%) Today
+$0.0025 (+0.51%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SYN and other ETFs, options, and stocks.

About SYN

Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the health of patients. Its product portfolio includes SYN-010 and SYN-004.

CEO
Steven A. Shallcross
Employees
10
Headquarters
Rockville, Maryland
Founded
2001

SYN Key Statistics

Market Cap
65.30M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.42M
High Today
$0.5096
Low Today
$0.48
Open Price
$0.48
Volume
1.33M
52 Week High
$1.70
52 Week Low
$0.261

SYN Earnings

-$0.27
-$0.18
-$0.09
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure